Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 May 2019 | Story Ruan Bruwer | Photo Varsity Sports
Lefébre Rademan
Lefébre Rademan, new captain of the Free State Crinums netball team, could be one of the star players in the Premier League. She is a fifth-year Education student.

The Free State Crinums netball team, a de facto Kovsie team with all 15 squad members enrolled for courses at the University of the Free State (UFS), will draw inspiration from their success in last year’s Varsity netball tournament. The Kovsies won the student competition for a record third time. 

During the weekend of 10 May 2019, the Crinums will play their first match in the 2019 Premier League. They lost a couple of key players in captain Alicia Puren, Protea Khanyisa Chawane, (both playing for the national invitational team in the league), Khomotso Mamburu (moved to Cape Town), and Meagan Roux (injured). They do, however, still have the services of players such as Tanya von Berg (playing in her sixth Premier League, one of only a handful of players to do so), Lefébre Rademan, Sikholiwe Mdletshe, Ané Retief, Gertriana Retief, and Rieze Straeuli. Rademan is the new captain and was one of the standout players in last year’s Varsity netball, earning three Player of the Match awards, including the Player of the Final. 

The team will again be coached by Burta de Kock, who is also the head coach of the Kovsies. Under her leadership, the Crinums won the Premier League for the first three years (2014 to 2016). Last year, the Crinums ended fourth. De Kock will be assisted by Martha Mosoahle-Samm. She is a former Protea assistant coach who also captained South Africa and played for the UFS between 1997 and 1999.

There are four first-year students in the squad of 15 players: Oageng Khasake (wing attack), Ancia Pienaar (goalkeeper), Rolene Streutker (goal shooter), Boitumelo Mahloko (goal defence). Pienaar and Mahloko both represented South Africa at junior level in 2018.

■ Crinums squad: Ané Retief, Gertriana Retief, Jana Scholtz, Lefébre Rademan, Sikholiwe Mdletshe, Tanya von Berg, Rieze Straeuli, Claudia van den Berg, Zandré Smit, Oageng Khasake, Bianca de Wee, Ancia Pienaar, Rolene Streutker, Chanel Vrey, Boitumelo Mahloko.


News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept